Cargando…
Atypical Chronic Myeloid Leukemia: Where Are We Now?
Atypical chronic myeloid leukemia, BCR-ABL1 negative (aCML) is a rare myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) with a high rate of transformation to acute myeloid leukemia, and poor survival. Until now, the diagnosis has been based on morphological grounds only, possibly maki...
Autores principales: | Crisà, Elena, Nicolosi, Maura, Ferri, Valentina, Favini, Chiara, Gaidano, Gianluca, Patriarca, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555965/ https://www.ncbi.nlm.nih.gov/pubmed/32962122 http://dx.doi.org/10.3390/ijms21186862 |
Ejemplares similares
-
Precision Medicine Management of Chronic Lymphocytic Leukemia
por: Moia, Riccardo, et al.
Publicado: (2020) -
Precision Medicine in Systemic Mastocytosis
por: Nicolosi, Maura, et al.
Publicado: (2021) -
Acute promyelocytic leukemia: where did we start, where are we now, and the future
por: Coombs, C C, et al.
Publicado: (2015) -
Hairy Cell Leukemia Treatment: Where We Are Now?
por: Krstevska, Svetlana, et al.
Publicado: (2011) -
A step ahead toward precision medicine for chronic lymphocytic leukemia
por: Patriarca, Andrea, et al.
Publicado: (2020)